255 related articles for article (PubMed ID: 1934379)
1. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
[TBL] [Abstract][Full Text] [Related]
2. Escalating nitrate dose overcomes early attenuation of hemodynamic effect caused by nitrate tolerance in patients with heart failure.
Mehra A; Shotan A; Ostrzega E; Vasquez-Johnson J; Elkayam U
Am Heart J; 1995 Oct; 130(4):798-805. PubMed ID: 7572589
[TBL] [Abstract][Full Text] [Related]
3. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
[TBL] [Abstract][Full Text] [Related]
4. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
Mehra A; Ostrzega E; Shotan A; Johnson JV; Elkayam U
Am J Cardiol; 1992 Nov; 70(15):1310-4. PubMed ID: 1442583
[TBL] [Abstract][Full Text] [Related]
5. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease.
Jørgensen LH; Thaulow E; Bredesen J; Refsum HE
Clin Cardiol; 2000 Jun; 23(6):427-32. PubMed ID: 10875033
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure.
Mehra A; Shotan A; Ostrzega E; Hsueh W; Vasquez-Johnson J; Elkayam U
Circulation; 1994 Jun; 89(6):2595-600. PubMed ID: 8205670
[TBL] [Abstract][Full Text] [Related]
7. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
Marmor A
Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337
[TBL] [Abstract][Full Text] [Related]
9. Short and long-acting oral nitrates for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of intravenous isosorbide dinitrate and nitroglycerine in acute myocardial infarction and elevated pulmonary artery wedge pressure.
Roth A; Weber L; Freidenberger L; Rahimtoola SH; Elkayam U
Chest; 1987 Feb; 91(2):190-6. PubMed ID: 3100145
[TBL] [Abstract][Full Text] [Related]
11. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
12. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
Elkayam U; Bitar F
Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic study of the development of tolerance in intravenous nitrate therapy].
Unverdorben M; Pfeiffer F; Kunkel B; Bachmann K
Z Kardiol; 1989; 78 Suppl 2():88-94; discussion 115-7. PubMed ID: 2686259
[TBL] [Abstract][Full Text] [Related]
15. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
16. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
17. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
Dalal JJ; Parker JO
Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of losartan, captopril, and furosemide in preventing nitrate tolerance and improving control of unstable angina pectoris.
Cotter G; Metzkor-Cotter E; Kaluski E; Blatt A; Litinsky I; Baumohl Y; Moshkovitz Y; Vered Z; Zaidenstein R; Golik A
Am J Cardiol; 1998 Nov; 82(9):1024-9. PubMed ID: 9817475
[TBL] [Abstract][Full Text] [Related]
19. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
Lewis BS; Hardoff R; Halon DA
Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
[TBL] [Abstract][Full Text] [Related]
20. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
